Molecular genetic study of Pompe disease in Chinese patients in Taiwan
Corresponding Author
Tsang-Ming Ko
Department of Obstetrics and Gynecology, College of Medicine, National Taiwan University, Taipei
Department of Genetic Health, College of Medicine, National Taiwan University, Taipei
Department of Obstetrics and Gynecology, National Taiwan University Hospital, No. 7, Chungshan South Road, Taipei, Taiwan. FAX: 886-223970515Search for more papers by this authorWuh-Liang Hwu
Department of Genetic Health, College of Medicine, National Taiwan University, Taipei
Department of Pediatrics, College of Medicine, National Taiwan University, Taipei
Search for more papers by this authorYu-Wan Lin
Department of Genetic Health, College of Medicine, National Taiwan University, Taipei
Search for more papers by this authorLi-Hui Tseng,
Department of Genetic Health, College of Medicine, National Taiwan University, Taipei
Search for more papers by this authorHsiao-Lin Hwa
Department of Obstetrics and Gynecology, College of Medicine, National Taiwan University, Taipei
Department of Genetic Health, College of Medicine, National Taiwan University, Taipei
Search for more papers by this authorTso-Ren Wang
Department of Genetic Health, College of Medicine, National Taiwan University, Taipei
Department of Pediatrics, College of Medicine, National Taiwan University, Taipei
Search for more papers by this authorSou-Ming Chuang
Department of Genetic Health, College of Medicine, National Taiwan University, Taipei
Search for more papers by this authorCorresponding Author
Tsang-Ming Ko
Department of Obstetrics and Gynecology, College of Medicine, National Taiwan University, Taipei
Department of Genetic Health, College of Medicine, National Taiwan University, Taipei
Department of Obstetrics and Gynecology, National Taiwan University Hospital, No. 7, Chungshan South Road, Taipei, Taiwan. FAX: 886-223970515Search for more papers by this authorWuh-Liang Hwu
Department of Genetic Health, College of Medicine, National Taiwan University, Taipei
Department of Pediatrics, College of Medicine, National Taiwan University, Taipei
Search for more papers by this authorYu-Wan Lin
Department of Genetic Health, College of Medicine, National Taiwan University, Taipei
Search for more papers by this authorLi-Hui Tseng,
Department of Genetic Health, College of Medicine, National Taiwan University, Taipei
Search for more papers by this authorHsiao-Lin Hwa
Department of Obstetrics and Gynecology, College of Medicine, National Taiwan University, Taipei
Department of Genetic Health, College of Medicine, National Taiwan University, Taipei
Search for more papers by this authorTso-Ren Wang
Department of Genetic Health, College of Medicine, National Taiwan University, Taipei
Department of Pediatrics, College of Medicine, National Taiwan University, Taipei
Search for more papers by this authorSou-Ming Chuang
Department of Genetic Health, College of Medicine, National Taiwan University, Taipei
Search for more papers by this authorAbstract
Pompe disease is caused by mutations in the acid α-glucosidase (GAA) gene. Multiple kinds of mutations in the GAA gene have been reported worldwide. In order to elucidate the molecular basis of the disease in Taiwanese patients of Chinese origin, we have recruited 11 unrelated families who had at least one member with Pompe disease for study. We used 16 pairs of oligonucleotide primers to amplify all the coding regions from exon 2 to 20 in the family members. The coding regions were sequenced on both the sense and antisense strands. We identified 7 different mutations in 17 alleles but failed to identify the defects in the other 5 alleles. The most common defect was D645E (Asp645Glu), accounting for 36% (8/22 alleles) of mutations, followed by G615R (Gly615Arg) (3 alleles); 1411del4 (Glu471-shift) (2 alleles); and one allele each of R600H (Arg600His); ΔN675 (ΔAsn675); 2380delC (Arg794-shift) and 2815delGT (Val939-shift). The molecular defects of Pompe disease are highly heterogeneous in Chinese. Characterization of the molecular defects of the disease is useful for a genotype-phenotype correlation and for genetic counseling and prenatal diagnosis. Hum Mutat 13:380–384, 1999. © 1999 Wiley-Liss, Inc.
REFERENCES
- Adams EM, Griffith L, Segal A, Plotz PH, Raben N. 1996. A novel splicing mutation is responsible for a juvenile phenotype of glycogen-storage disease type II. Am J Hum Genet 59 suppl A244 (Abstract).Medline
- Boerkoel CF, Exelbert R, Nicastri C, Nichols RC, Miller FW, Plotz PH, Raben N. 1995. Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II. Am J Hum Genet 56: 887–897.Medline
- Chen YT, Burchell A. 1995. Glycogen storage disease. In: CR Scriver, editors. The metabolic and molecular basis of inherited disease. New York: McGraw-Hill. p 935–965.
- Hermans MMP, de Graaff E, Kroos MA, Wisselaar HA, Oostra BA, Reuser AJJ. 1991a. Identification of a point mutation in the human lysosomal α-glucosidase gene causing infantile glycogenosis type II. Biochem Biophy Res Comm 179: 919–926.Medline
- Hermans MMP, Kroos MA, van Beeumens J, Oostra BA, Reuser AJJ. 1991b. Human lysosomal α-glucosidase- characterization of the catalytic site. J Biol Chem 266: 13507–13512.Medline
- Hermans MMP, Kroos MA, de Graaff E, Oostra BA, Reuser AJJ. 1993a. Two mutations affecting the transport and maturation of lysosomal α-glucosidase in an adult case of glycogen storage disease type II. Hum Mut 2: 268–273.Medline
- Hermans MMP, Svetkey LP, Oostra BA, Chen TY, Reuser AJJ. 1993b. The loss of a polymorphic glycosylation site caused by Thr-927→Ile is linked to a second polymorphic Val-186→Ile substitution in lysosomal alpha-glucosidase of American blacks. Genomics 16: 300–301.Medline
- Hermans MMP, De Graaff E, Kroos MA, Wisselaar HA, Willemsen R, Oostra BA, Reuser AJJ. 1993c. The conservative substitution Asp-645→Glu in lysosomal α-glucosidase affects transport and phosphorylation of the enzyme in an adult patient with glycogen-storage disease type II. Biochem J 289: 687–693.Medline
- Hermans MMP, de Graaff E, Kroos MA, Mohkamsing S, Eussen BJ, Joosse M, Willemsen R, Kleijer W, Oostra BA, Reuser AJJ. 1994. The effect of a single base pair deletion (ΔT525) and a C1634T missense mutation (pro545leu) on the expression of lysosomal α-glucosidase in patients with glycogen storage disease type II. Hum Mol Genet 3: 2213–2218.Medline
- Hoefsloot LH, Hoogeveen-Westerveld M, Kroos MA, van Beeumen J, Reuser AJJ, Oostra BA. 1988. Primary structure and processing of lysosomal α-glucosidase; homology with intestinal sucrase-isomaltase complex. EMBO J 7: 1697–1704.Medline
- Hoefsloot LH, Hoogeveen-Westerveld M, Reuser AJJ, Oostra BA. 1990. Characterization of the human lysosomal α-glucosidase gene. Biochem J 272: 493–497.Medline
- Huie ML, Chen AS, Brooks SS, Grix A, Hirschhorn R. 1994a. A de novo 13 nt deletion, a newly identified C647W missense mutation and a deletion of exon 18 in infantile onset glycogen storage disease type II (GSDII). Hum Mol Genet 3: 1081–1087.Medline
- Huie ML, Chen AS, Tsujino S, Shanske S, DiMauro S, Engel AG, Hirschhorn R. 1994b. Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (–13T→G) mutation in a majority of patients and a novel IVS10 (+1GT→CT) mutation. Hum Mol Genet 3: 2231–2236.Medline
- Lin CY, Shieh JJ. 1995. Identification of a de novo point mutation resulting in infantile form of Pompe's disease. Biochem Biophy Res Comm 208: 886–893.Medline
- Martiniuk F, Mehler M, Pellicer A, Tzall S, La Badie G, Hobart C, Ellenbogen A, Hirschhorn R. 1986. Isolation of a cDNA for human acid α-glucosidase and detection of genetic heterogeneity for mRNA in three α-glucosidase-deficient patients. Proc Natl Acad Sci USA 83: 9641–9644.
- Martiniuk F, Mehler M, Tzall S, Meredith G, Hirschhorn R. 1990a. Sequence of the cDNA and 5′-flanking region for human acid α-glucosidase, detection of an intron in the 5′ untranslated leader sequence, definition of 18-bp polymorphisms, and differences with previous cDNA and amino acid sequences. DNA Cell Biol 9: 85–94.Medline
- Martiniuk F, Mehler M, Tzall S, Meredith G, Hirschhorn R. 1990b. Extensive genetic heterogeneity in patients with acid alpha glucosidase deficiency as detected by abnormalities of DNA and mRNA. Am J Hum Genet 47: 73–78.Medline
- Martiniuk F, Bodkin M, Tzall S, Hirschhorn R. 1991. Isolation and partial characterization of the structural gene for human acid alpha glucosidase. DNA Cell Biol 10: 283–292.Medline
- Reuser AJJ, Kroos MA, Hermans MMP, Bijvoet AGA, Verbeet MP, Van Diggelen OP, Kleijer WJ, Van der Ploeg AT. 1995. Glycogenosis type II (acid maltase deficiency). Muscle Nerve suppl 3: s61–s69.
- Shieh JJ, Wang LY, Lin CY. 1994. Point mutation in Pome disease in Chinese. J Inher Metab Dis 17: 145–148.Medline
- Shieh JJ, Lin CY. 1996. Identification of a small deletion in one allele of patients with infantile form of glycogen storage disease type II. Biochem Biophy Res Comm 219: 322–326.Medline
- Tsujino S, Tashiro T, Kobayashi K, Goto Y, Nonaka I, Sakuragawa N. 1996. Molecular genetic basis of acid α-glucosidase deficiency in Japanese patients. Am J Hum Genet 59 suppl: A290 (Abstract).
- Tsunoda H, Ohshima T, Tohyama J, Sasaki M, Sakuragawa N, Martinuik F. 1996. Acid alpha-glucosidase deficiency: identification and expression of a missense mutation (S529V) in a Japanese adult phenotype. Hum Genet 97: 496–499.Medline
- Wisselaar HA, Kroos MA, Hermans MMP, van Beeumen J, Reuser AJJ. 1993. Structural and functional changes of lysosomal acid α-glucosidase during intracellular transport and maturation. J Biol Chem 268: 2223–2231.Medline
- Van der Kraan M, Kroos MA, Joosse M, Bijvoet AGA, Verbeet MP, Kleijer WJ, Reuser AJJ. 1994. Deletion of exon 18 is a frequent mutation in glycogen storage disease type II. Biochem Biophy Res Comm 203: 1535–1541.Medline
- Zhong N, Martiniuk F, Tzall S, Hirschhorn R. 1991. Identification of a missense mutation in one allele of a patient with Pompe disease, and use of endonuclease digestion of PCR-amplified RNA to demonstrate lack of mRNA expression from the second allele. Am J Hum Genet 49: 635–645.Medline